Moderate riskFDA DeviceClass II

Aniara Diagnostica ZYMUTEST HIA IgG ELISA kit recalled for incorrect control values

Lot FD1265 of the ZYMUTEST HIA IgG diagnostic kit was shipped with an outdated instruction flyer that contained incorrect values for the positive control. This could lead to misinterpretation of test results if users rely on the wrong reference values.

From the FDA notice · Read the official notice ↗

What to do

  1. If you have lot FD1265, do not use the outdated flyer included in the package.
  2. Contact Aniara Diagnostica LLC for corrected control values.
  3. Review test results from this lot against the correct positive control values before reporting them.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040A
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
359 units
Illnesses reported
None reported
Manufactured in
7768 Service Center Dr, West Chester, OH, United States
Classification
Class II
Recall number
Z-2171-2026

In the FDA's words

Description
ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040A Kits from lot FD1265 had been packaged on 17 October 2024 and put on the market with an outdated flyer (8 October 2024), containing incorrect values for the positive control. UDI-DI: 03663537018763; Lot Number: FD1265 Distribution: US Nationwide distribution in the states of CA, GA, MN, MO, NC, NM, NY, VA, WA, and WI Affected quantity: 359 units
Hazard
Kits from lot FD1265 had been packaged on 17 October 2024 and put on the market with an outdated flyer (8 October 2024), containing incorrect values for the positive control.

Related topics